(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...

New data reveals that Januvia was as effective as Glucotrol in reducing blood sugar levels in patients with type 2 diabetes.Merck (NYSE: MRK) announced today its drug Januvia was as effective as the ...

NEW YORK, June 27 (Reuters) - Two widely used diabetes medicines, Januvia and Byetta, pose no additional risk for cases of inflamed pancreas compared with other diabetes drugs, according to an ...

Unichem has obtained tentative approval from the Food and Drug Administration for sitagliptin tablets in dosage strengths of 25 mg, 50 mg, and 100 mg The medication is a generic of Merck Sharpe and ...

Amylin Pharmaceuticals and Eli Lilly today said their diabetes drug Byetta worked better at reducing blood-sugar levels following a meal compared with Merck's Januvia. The results, based on a a ...

Aug 9 (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's MRK.N diabetes drug Januvia, were contaminated with a possible carcinogen.

The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, which is used to treat blood cancers. The savings range from 79% for Januvia, used to manage diabetes, to 38% for ...

In a phase 3 trial of patients with type 2 diabetes not controlled with metformin plus sulfonylurea, adding canagliflozin (Invokana, Janssen Pharmaceuticals) improved glycemic control better than ...

Although designed to treat Type 2 diabetes, some medications have been involved recently in diabetes drug lawsuits. LawyersandSettlements.com, the nation's premier publication for online legal news ...

Merck & Co., after settling with nearly two dozen drugmakers aiming to launch generics of its blockbuster Type 2 diabetes med Januvia, has successfully parried a Viatris patent assault in court. A U.S ...

The Biden administration on Tuesday tabbed 10 commonly used prescription drugs, including some that treat diabetes, for price negotiations with their manufacturers in a bid to put the brakes on rising ...